| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1454 | 2018 |
| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 1336 | 2022 |
| Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease M Alegret, C Junqué, F Valldeoriola, P Vendrell, M Pilleri, J Rumia, ... Archives of Neurology 58 (8), 1223-1227, 2001 | 318 | 2001 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 223 | 2021 |
| A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved A Espinosa, M Alegret, S Valero, G Vinyes-Junqué, I Hernández, ... Journal of Alzheimer's Disease 34 (3), 769-780, 2013 | 217 | 2013 |
| Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ ACE project S Moreno‐Grau, I De Rojas, I Hernández, I Quintela, L Montrreal, ... Alzheimer's & Dementia 15 (10), 1333-1347, 2019 | 154 | 2019 |
| Visuospatial deficits in parkinsons disease assessed by judgment of line orientation test: Error analyses and practice effects A Montse, V Pere, J Carme, V Francesc, T Eduardo Journal of clinical and experimental neuropsychology 23 (5), 592-598, 2001 | 145 | 2001 |
| Obsessive-compulsive symptoms in Parkinson's disease M Alegret, C Junque, F Valldeoriola, P Vendrell, MJ Marti, E Tolosa Journal of Neurology, Neurosurgery & Psychiatry 70 (3), 394-396, 2001 | 143 | 2001 |
| Follow-up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility gene A Ruiz, S Heilmann, T Becker, I Hernández, H Wagner, M Thelen, ... Translational psychiatry 4 (2), e358-e358, 2014 | 132 | 2014 |
| The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease C Antúnez, M Boada, A González-Pérez, J Gayán, R Ramírez-Lorca, ... Genome medicine 3, 1-8, 2011 | 120 | 2011 |
| Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment A Lacour, A Espinosa, E Louwersheimer, S Heilmann, I Hernández, ... Molecular psychiatry 22 (1), 153-160, 2017 | 116 | 2017 |
| Ecological assessment of executive functions in mild cognitive impairment and mild Alzheimer’s disease ANA Espinosa, M Alegret, M Boada, G Vinyes, S Valero, P Martínez-Lage, ... Journal of the International Neuropsychological Society 15 (5), 751-757, 2009 | 112 | 2009 |
| Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease M Alegret, F Valldeoriola, MJ Martí, M Pilleri, C Junqué, J Rumià, E Tolosa Movement Disorders 19 (12), 1463-1469, 2004 | 103 | 2004 |
| Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-β concentrations and cognition outcomes in Alzheimer’s disease patients … M Boada, F Anaya, P Ortiz, J Olazarán, JR Shua-Haim, TO Obisesan, ... Journal of Alzheimer's Disease 56 (1), 129-143, 2017 | 98 | 2017 |
| Normative data of a brief neuropsychological battery for Spanish individuals older than 49 M Alegret, A Espinosa, G Vinyes-Junqué, S Valero, I Hernández, ... Journal of Clinical and Experimental Neuropsychology 34 (2), 209-219, 2012 | 90 | 2012 |
| Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease M Alegret, M Boada-Rovira, G Vinyes-Junqué, S Valero, A Espinosa, ... Journal of clinical and experimental neuropsychology 31 (7), 860-867, 2009 | 87 | 2009 |
| Type 2 diabetes is an independent risk factor for dementia conversion in patients with mild cognitive impairment A Ciudin, A Espinosa, O Simo-Servat, A Ruiz, M Alegret, C Hernandez, ... Journal of Diabetes and its Complications 31 (8), 1272-1274, 2017 | 84 | 2017 |
| Decreased frontal choline and neuropsychological performance in preclinical Huntington disease B Gomez-Anson, M Alegret, E Munoz, A Sainz, GC Monte, E Tolosa Neurology 68 (12), 906-910, 2007 | 84 | 2007 |
| Differentiated clinical presentation of early and late-onset Alzheimer’s disease: is 65 years of age providing a reliable threshold? A Palasí, B Gutiérrez-Iglesias, M Alegret, F Pujadas, M Olabarrieta, ... Journal of neurology 262 (5), 1238-1246, 2015 | 82 | 2015 |
| Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number B Gómez-Ansón, M Alegret, E Munoz, GC Monte, E Alayrach, A Sanchez, ... Parkinsonism & related disorders 15 (3), 213-219, 2009 | 82 | 2009 |
